DE69425655T2 - Antagonisten des fibrinogenrezeptors - Google Patents

Antagonisten des fibrinogenrezeptors

Info

Publication number
DE69425655T2
DE69425655T2 DE69425655T DE69425655T DE69425655T2 DE 69425655 T2 DE69425655 T2 DE 69425655T2 DE 69425655 T DE69425655 T DE 69425655T DE 69425655 T DE69425655 T DE 69425655T DE 69425655 T2 DE69425655 T2 DE 69425655T2
Authority
DE
Germany
Prior art keywords
receptor antagonists
fibrinogen receptor
image
fibrinogen
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69425655T
Other languages
English (en)
Other versions
DE69425655D1 (de
Inventor
D Hartman
Wasyl Halczenko
D Prugh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE69425655D1 publication Critical patent/DE69425655D1/de
Application granted granted Critical
Publication of DE69425655T2 publication Critical patent/DE69425655T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)
DE69425655T 1993-05-11 1994-05-02 Antagonisten des fibrinogenrezeptors Expired - Fee Related DE69425655T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/062,510 US5334596A (en) 1993-05-11 1993-05-11 Fibrinogen receptor antagonists
PCT/US1994/004757 WO1994026745A1 (en) 1993-05-11 1994-05-02 Fibrinogen receptor antagonists

Publications (2)

Publication Number Publication Date
DE69425655D1 DE69425655D1 (de) 2000-09-28
DE69425655T2 true DE69425655T2 (de) 2001-04-19

Family

ID=22042946

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69425655T Expired - Fee Related DE69425655T2 (de) 1993-05-11 1994-05-02 Antagonisten des fibrinogenrezeptors

Country Status (9)

Country Link
US (1) US5334596A (de)
EP (1) EP0698023B1 (de)
JP (1) JPH08509982A (de)
AT (1) ATE195737T1 (de)
AU (1) AU681668B2 (de)
CA (1) CA2161787A1 (de)
DE (1) DE69425655T2 (de)
ES (1) ES2148329T3 (de)
WO (1) WO1994026745A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5494921A (en) * 1994-09-16 1996-02-27 Merck & Co., Inc. Fibrinogen receptor antagonists
US5646000A (en) * 1994-09-29 1997-07-08 Merck & Co., Inc. Compounds and methods for identifying activated platelets
AU3619795A (en) * 1994-10-11 1996-05-02 Takeda Chemical Industries Ltd. Substituted heterobicyclic alkyl amines and their use as squalene oxide cyclase inhibitors
WO1996018399A1 (en) * 1994-12-13 1996-06-20 Euro-Celtique, S.A. Aryl thioxanthines
CA2206804C (en) * 1994-12-13 2002-03-19 Euro-Celtique, S.A. Trisubstituted thioxanthines
US5719144A (en) * 1995-02-22 1998-02-17 Merck & Co., Inc. Fibrinogen receptor antagonists
ZA963391B (en) * 1995-05-24 1997-10-29 Du Pont Merck Pharma Isoxazoline fibrinogen receptor antagonists.
US5852045A (en) * 1995-10-19 1998-12-22 Merck & Co., Inc. Fibrinogen receptor antagonists
AU2044297A (en) * 1996-03-29 1997-10-22 Meiji Seika Kaisha Ltd. Novel heterocyclic compounds having platelet aggregation inhibitory effects
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
EP0920345A4 (de) * 1996-06-19 2006-05-10 Vyteris Inc Iontophoretische abscheidung von zelladhäsions-inhibitoren
AU3640997A (en) 1996-06-19 1998-01-07 Du Pont Pharmaceuticals Company Iontophoretic delivery of integrin inhibitors
US6248746B1 (en) 1998-01-07 2001-06-19 Euro-Celtique S.A. 3-(arylalkyl) xanthines
US6623981B2 (en) * 1998-01-27 2003-09-23 Bristol-Myers Squibb Company Detection of patients at risk for developing integrin antagonist/agonist mediated disease states
MXPA05000722A (es) * 2002-07-17 2005-04-08 Warner Lambert Co Combinacion de un inhibidor alosterico carboxilico de la metaloproteinasa-13 de la matriz con un inhibidor selectivo de la ciclooxigenasa-2 que no es celecoxib o valdecoxib.
US6882901B2 (en) * 2002-10-10 2005-04-19 Shao-Wei Gong Ultra-precision robotic system
CN101186612B (zh) * 2006-11-15 2012-10-03 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的吡咯啉衍生物及其制备和应用
JP2020504711A (ja) 2016-12-21 2020-02-13 バイオセリックス， インコーポレイテッド タンパク質を標的とすることにおいて使用するための、チエノピロール誘導体、その組成物、方法、および使用
JP2021519786A (ja) 2018-03-30 2021-08-12 バイオセリックス， インコーポレイテッド チエノピリミジノン化合物

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164404A (en) * 1973-06-25 1979-08-14 American Cyanamid Company Dithiindicarboximide, dithiolanedicarboximide, thiapyrandicarboximide and pyrandicarboximide derivatives as plant growth regulants
US4313947A (en) * 1974-06-24 1982-02-02 Otsuka Pharmaceutical Co., Ltd. Platelet aggregation inhibiting 2-oxyindoles, their compositions and method of use
DE2549999A1 (de) * 1975-11-07 1977-05-12 Boehringer Mannheim Gmbh Piperidin-derivate und verfahren zu ihrer herstellung
FR2334358A1 (fr) * 1975-12-12 1977-07-08 Sogeras Nouveaux medicaments derives de l'indole
US4064125A (en) * 1976-10-29 1977-12-20 E. R. Squibb And Sons, Inc. Substituted amides having antiinflammatory activity
GB1576511A (en) * 1977-03-29 1980-10-08 Parcor Thieno(2,3 - c) and (3,2 - c) pyridines process for their preparation and therapeutic applications thereof
EP0021592B1 (de) * 1979-05-23 1983-09-28 BEECHAM - WUELFING GmbH & Co. KG Benzolsulfonamid-Derivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Medikamente
ZA821020B (en) * 1981-02-18 1983-10-26 Thomae Gmbh Dr K Azepine derivatives, process for their preparation and pharmaceutical compositions thereof
DK623586A (da) * 1985-12-27 1987-06-28 Eisai Co Ltd Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
KR880007441A (ko) * 1986-12-11 1988-08-27 알렌 제이.스피겔 스피로-치환된 글루타르아미드 이뇨제
US4898867A (en) * 1987-09-16 1990-02-06 Taiho Pharmaceutical Company, Limited Thienopyrimidine derivaties as aldose-reductase inhibitors
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
US5039805A (en) * 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
CA2008116C (en) * 1989-02-23 2001-11-20 Thomas Weller Glycine derivatives
US5026700A (en) * 1989-05-16 1991-06-25 Merrell Dow Pharmaceuticals Certain quinolines and thienopyridines as excitatory amino acid antagonists
NZ234264A (en) * 1989-06-29 1993-05-26 Warner Lambert Co N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives, and pharmaceutical compositions
FR2652579B1 (fr) * 1989-10-02 1992-01-24 Sanofi Sa Derives d'hydroxy-2 thiophene et furanne condenses avec un cycle azote, sur procede de preparation et leur application en therapeutique.
US5064814A (en) * 1990-04-05 1991-11-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-thrombotic peptide and pseudopeptide derivatives
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.
DE4023048A1 (de) * 1990-07-20 1992-01-23 Basf Ag Dicarbonsaeureimide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
IL99537A (en) * 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical preparations containing them
NZ239876A (en) * 1990-09-27 1993-12-23 Merck & Co Inc Glycyl-b-alanine derivatives and pharmaceutical compositions thereof.
IL99539A0 (en) * 1990-09-27 1992-08-18 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
US5252581A (en) * 1992-07-20 1993-10-12 Hoechst-Roussel Pharmaceuticals Inc. Substituted aminothienopyridines, pharmaceutical composition and use
US5260261A (en) * 1992-12-11 1993-11-09 Imperial Chemical Industries Plc Fused pyridine herbicides

Also Published As

Publication number Publication date
AU681668B2 (en) 1997-09-04
AU6822194A (en) 1994-12-12
ES2148329T3 (es) 2000-10-16
US5334596A (en) 1994-08-02
EP0698023B1 (de) 2000-08-23
JPH08509982A (ja) 1996-10-22
CA2161787A1 (en) 1994-11-24
ATE195737T1 (de) 2000-09-15
EP0698023A4 (de) 1997-07-02
DE69425655D1 (de) 2000-09-28
WO1994026745A1 (en) 1994-11-24
EP0698023A1 (de) 1996-02-28

Similar Documents

Publication Publication Date Title
DE69425655D1 (de) Antagonisten des fibrinogenrezeptors
ATE219938T1 (de) Neue 4-arylpiperazine und 4-arylpiperidine
DE69207351D1 (de) Fibrinogen-Rezeptor-Antagoniste
MX9101311A (es) Antagonistas receptores de fibrinogeno
KR960700722A (ko) 피브리노겐 수용체 길항제(Fibrinogen receptor antagonists)
BR9106518A (pt) Preparacao de piperidinas substituidas
DE69426452D1 (de) Fibrinogen receptor antagonisten
ZA949291B (en) Isoxazoline compounds useful as fibrinogen receptor antagonists
ES2117654T3 (es) Antagonistas de colecistoquinina.
NO930205L (no) Benzimidazoler, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
KR950700305A (ko) 칼슘 통로 길항제로서 아자바이사이클로 화합물(Azabicyclo compounds as calcium channel antagonists)
FI943359A0 (fi) Atsasykliset-heterosykliset yhdisteet angiotensiini II reseptoriantagonisteina
KR930009339U (ko) 프리크랙 발생용 복식지그
IT1265314B1 (it) Acilsulfammidi ad attivita' antitumorale
IT1269531B (it) Derivati ammidici ad attivita' fungicida
KR950022014U (ko) 싱크와이어 고정용 플라이백 트랜스포머
KR950011943U (ko) 상관부재 결합용 클립

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee